YolTech Therapeutics Co., Ltd
3 clinical trials · Sponsor
◉ Watch YolTech Therapeutics Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1) (NCT07776626) | YolTech Therapeutics Co., Ltd | 2026-08-01 |
| Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1) (NCT07587021) | YolTech Therapeutics Co., Ltd | 2026-08-01 |
| A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) (NCT06539208) | YolTech Therapeutics Co., Ltd | 2024-05-23 |
Track YolTech Therapeutics Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.